Our latest Investing Matters Podcast episode with QuotedData's Edward Marten has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksStandard Chartered Regulatory News (STAN)

Share Price Information for Standard Chartered (STAN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 679.00
Bid: 679.00
Ask: 679.40
Change: -0.20 (-0.03%)
Spread: 0.40 (0.059%)
Open: 679.80
High: 683.80
Low: 677.60
Prev. Close: 679.20
STAN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Convertible Securities - Price Adjustment

11 Dec 2015 08:52

RNS Number : 7669I
Standard Chartered PLC
11 December 2015
 



Standard Chartered PLC

11 December 2015

NOT FOR DISTRIBUTION OR TRANSMISSION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES

Notice of adjustment of the Conversion Price of U.S.$2,000,000,000 Fixed Rate Resetting Perpetual Subordinated Contingent Convertible Securities (Rule 144A ISIN: US853254AT77; Regulation S ISIN: USG84228CE61) (the "Securities")

Please be advised that further to (i) its announcement dated 30 March 2015 in relation to the issuance of the Securities, and (ii) its announcement dated 3 November 2015, prospectus dated 18 November 2015, supplementary prospectus dated 1 December 2015 and announcement dated 11 December 2015 (the "Rights Issue Results Announcement"), all in relation to the 2 for 7 rights issue of 728,432,451 new Ordinary Shares at 465 pence each (the "Rights Issue"), Standard Chartered PLC has, in accordance with the terms and conditions of the Securities (the "Terms and Conditions"), given notice to the Securityholders that the Conversion Price per Ordinary Share in respect of the Securities has been adjusted in accordance with the Terms and Conditions (the "Adjustment"). The Adjustment became effective on 23 November 2015 (the "Effective Date"). Prior to the Effective Date, the Conversion Price per Ordinary Share was U.S.$11.424. The adjusted Conversion Price per Ordinary Share, computed in accordance with Condition 7(e)(iv) of the Terms of Conditions, is U.S.$10.865.

Capitalised terms not otherwise defined in this announcement shall have the meanings given to them in the Terms and Conditions.

For further information with respect to the adjustment of the Conversion Price of the Securities, please paste the following URL into the address bar of the browser:

http://www.rns-pdf.londonstockexchange.com/rns/7669I_-2015-12-11.pdf

For further information, please contact:

James Hopkinson, Head of Investor Relations +44 (0)20 7885 7151

Jon Tracey, Global Head of Communications +44 (0)20 7885 7613

Shaun Gamble, Director, Media Relations +44 (0)20 7885 5934

 

DISCLAIMER - INTENDED ADDRESSEES

This announcement does not constitute an offer of any securities for sale.

The Securities and any ordinary shares which may be delivered upon conversion of the Securities have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act").

The distribution of this announcement in certain jurisdictions may be restricted by law. Persons into whose possession this announcement comes are required to inform themselves about and to observe any such restrictions.

This announcement has been prepared solely for information purposes and is not an offer (or a solicitation of an offer) to buy or sell any securities in any jurisdiction.

END

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCTBBRTMBIBMIA
Date   Source Headline
27th Mar 20246:22 pmRNSNotice to ADR Holders of 6.409% Preference Shares
27th Mar 20245:39 pmRNSTransaction in Own Shares
26th Mar 20245:35 pmRNSTransaction in Own Shares
26th Mar 20244:36 pmRNSDirector/PDMR Shareholding
25th Mar 20245:43 pmRNSTransaction in Own Shares
22nd Mar 20245:35 pmRNSTransaction in Own Shares
21st Mar 20245:55 pmRNSTransaction in Own Shares
20th Mar 20245:30 pmRNSTransaction in Own Shares
20th Mar 20243:08 pmRNSDirector/PDMR Shareholding
19th Mar 20246:05 pmRNSTransaction in Own Shares
19th Mar 20245:45 pmRNSPublication of Final Terms
18th Mar 20245:51 pmRNSTransaction in Own Shares
15th Mar 20245:53 pmRNSTransaction in Own Shares
15th Mar 20244:45 pmRNSHolding(s) in Company
15th Mar 20244:30 pmRNSDirector/PDMR Shareholding
15th Mar 20243:35 pmRNSDirector/PDMR Shareholding
15th Mar 202410:30 amRNSHolding(s) in Company
14th Mar 20246:05 pmRNSTransaction in Own Shares
14th Mar 20242:03 pmRNSTotal Voting Rights
14th Mar 202411:05 amRNSDirector/PDMR Shareholding
13th Mar 20246:02 pmRNSTransaction in Own Shares
13th Mar 20246:00 pmRNSPublication of Supplementary Prospectus
13th Mar 202411:26 amRNSOverseas Regulatory Announcement – Grant of awards
13th Mar 202410:45 amRNSDirector/PDMR Shareholding
12th Mar 20246:00 pmRNSTransaction in Own Shares
12th Mar 20242:54 pmRNSDirector/PDMR Shareholding
12th Mar 202410:57 amRNSOverseas Regulatory Announcement - Grant of awards
12th Mar 202410:00 amRNSStandard Chartered: Management Team Change
11th Mar 20246:23 pmRNSTransaction in Own Shares
8th Mar 20245:59 pmRNSTransaction in Own Shares
8th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 20246:02 pmRNSTransaction in Own Shares
6th Mar 202411:33 amRNSNotice of Redemption
5th Mar 20246:15 pmRNSTransaction in Own Shares
4th Mar 20246:04 pmRNSTransaction in Own Shares
1st Mar 20245:50 pmRNSTransaction in Own Shares
1st Mar 202412:00 pmRNSTotal Voting Rights
29th Feb 20246:15 pmRNSTransaction in Own Shares
29th Feb 20244:21 pmRNSPublication of Final Terms
29th Feb 20247:00 amRNSIssuance of U.S.$1bn Additional Tier 1 Securities
29th Feb 20247:00 amRNSTransaction in Own Shares
27th Feb 20246:09 pmRNSTransaction in Own Shares
26th Feb 202410:03 amRNSShare Buy-Back
23rd Feb 20242:39 pmRNSFull Year 2023 Pillar 3 Disclosures
23rd Feb 202412:13 pmRNSPublication of Supplementary Prospectus
23rd Feb 20247:00 amRNSAnnual Report 2023
23rd Feb 20247:00 amRNSAdditional Financial Information - Part 2
23rd Feb 20247:00 amRNSAdditional Financial Information - Part 1
23rd Feb 20247:00 amRNSSCPLC Final Results 2023
16th Feb 202410:00 amRNSDirectorate Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.